After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Immunome Inc is $909.28M. A total of 1.25 million shares were traded on the day, compared to an average of 1.02M shares.
In the most recent transaction, BIENAIME JEAN JACQUES bought 5,000 shares of IMNM for 9.38 per share on Jun 03 ’25. After the transaction, the Director now owns 36,415 company shares. In a previous transaction on Mar 25 ’25, BIENAIME JEAN JACQUES bought 7,800 shares at 7.78 per share. IMNM shares that Director owns now total 31,415.
Among the insiders who bought shares, SIEGALL CLAY B acquired of 137,100 shares on Mar 26 ’25 at a per-share price of $7.29. This resulted in the President and CEO holding 806,736 shares of IMNM after the transaction. In another insider transaction, BIENAIME JEAN JACQUES bought 7,000 shares at $8.21 per share on Mar 24 ’25. Company shares held by the Director now total 23,615.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IMNM has a high of $16.81 and a low of $5.15.
As of this writing, IMNM has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.59.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IMNM’s latest balance sheet shows that the firm has $49.23M in Cash & Short Term Investments as of fiscal 2021. There were $317.00k in debt and $9.73M in liabilities at the time. Its Book Value Per Share was $3.53, while its Total Shareholder’s Equity was $48.19M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
